Trial Profile
Understanding respiratory medication persistence in Australian patients with chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 24 Feb 2009 New trial record